listed · IPO · NSE SME · listed 25 June 2026
Avience Biomedicals Limited
Raised ₹30.24 Cr at ₹208 per share.
+90.0%
listing-day move
Price band
₹196 – ₹208
Issue price
₹208
Issue size
₹30.24 Cr
Return since listing
+14.90%
Company research
Tijori FinanceAvience Biomedicals is an innovative diagnostics solutions provider committed to empowering healthcare professionals with advanced technology. Recognized as a Startup and a Small-scale Industry under MSME.
Financials — ₹ crore
| Period | Revenue | PAT | Debt |
|---|---|---|---|
| Mar 2023 | 10.92 Cr | 0.71 Cr | 2.66 Cr |
| Mar 2024 | 23.96 Cr | 2.14 Cr | 15.13 Cr |
| Mar 2025 | 45.24 Cr | 7.23 Cr | 22.16 Cr |
Revenue mix
Manufacturing of Vitro-Diagnostic (IVD) products and medical devices
100%
Peer comparison
Company Mkt cap Revenue P/E P/B
AVIENCE 138 45.24 Cr 15.74 —
MOREPENLAB 2,873 1,811 Cr 30.29 2.3
Exchange filings
Fields captured from NSE and BSEIssue information
- Symbol
- AVIENCE
- Issue period
- 2026-06-18 to 2026-06-22
- Price range
- Rs.196 to Rs.208
- Red Herring Prospectus
- https://nsearchives.nseindia.com/emerge/corporates/content/AvienceBiomedicalsLimited_RHP.zip
Documents
Data sources: MONEYCONTROL , NSE , NSE , NSE . Data quality clean.